Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
34
HCAT Quote, Financials, Valuation and Earnings
Last price:
$7.11
Seasonality move
:
-12.17%
Day range:
$6.75 - $7.25
52-week range:
$5.42 - $11.41
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.39x
P/B ratio:
1.22x
Volume:
936.5K
Avg. volume:
571.5K
1-year change:
-21.2%
Market cap:
$432M
Revenue:
$295.9M
EPS (TTM):
-$1.35
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $154.9M | $188.8M | $241.9M | $276.2M | $295.9M | |
| Revenue Growth (YoY) | 37.64% | 21.88% | 28.11% | 14.18% | 7.13% | |
| Cost of Revenues | $75.3M | $98.1M | $124.4M | $143M | $164.1M | |
| Gross Profit | $79.6M | $90.8M | $117.6M | $133.2M | $131.8M | |
| Gross Profit Margin | 51.37% | 48.07% | 48.6% | 48.22% | 44.55% | |
| R&D Expenses | $46.3M | $53.5M | $62.7M | $75.7M | $72.6M | |
| Selling, General & Admin | $79M | $114.7M | $161M | $149.2M | $143.9M | |
| Other Inc / (Exp) | -$1.7M | -$8.5M | -- | -$126K | $4K | |
| Operating Expenses | $134.5M | $186.9M | $261.2M | $273.2M | $258.7M | |
| Operating Income | -$54.9M | -$96.1M | -$143.7M | -$140M | -$126.9M | |
| Net Interest Expenses | $3.4M | $11.6M | $16.5M | $1.6M | -- | |
| EBT. Incl. Unusual Items | -$60M | -$116.2M | -$160.1M | -$141.7M | -$117.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $142K | -$1.2M | -$6.9M | -$4.3M | $356K | |
| Net Income to Company | -$60.1M | -$115M | -$153.2M | -$137.4M | -$118.1M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$60.1M | -$115M | -$153.2M | -$137.4M | -$118.1M | |
| Basic EPS (Cont. Ops) | -$12.86 | -$2.91 | -$3.23 | -$2.56 | -$2.09 | |
| Diluted EPS (Cont. Ops) | -$12.86 | -$2.91 | -$3.23 | -$2.63 | -$2.09 | |
| Weighted Average Basic Share | $18.7M | $39.5M | $47.5M | $53.7M | $56.4M | |
| Weighted Average Diluted Share | $18.7M | $39.5M | $47.5M | $53.7M | $56.4M | |
| EBITDA | -$47.3M | -$85.9M | -$106.1M | -$86.1M | -$68.3M | |
| EBIT | -$56.5M | -$104.6M | -$143.7M | -$134.4M | -$110.5M | |
| Revenue (Reported) | $154.9M | $188.8M | $241.9M | $276.2M | $295.9M | |
| Operating Income (Reported) | -$54.9M | -$96.1M | -$143.7M | -$140M | -$126.9M | |
| Operating Income (Adjusted) | -$56.5M | -$104.6M | -$143.7M | -$134.4M | -$110.5M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $47.2M | $61.7M | $68.4M | $73.8M | $76.4M | |
| Revenue Growth (YoY) | 19.7% | 30.82% | 10.72% | 7.93% | 3.5% | |
| Cost of Revenues | $24.4M | $33.1M | $36.3M | $41.8M | $42.3M | |
| Gross Profit | $22.8M | $28.7M | $32M | $32M | $34M | |
| Gross Profit Margin | 48.4% | 46.41% | 46.84% | 43.36% | 44.58% | |
| R&D Expenses | $13.4M | $16.4M | $20.8M | $17.7M | $14.2M | |
| Selling, General & Admin | $27.9M | $43.9M | $44.6M | $28.7M | $23.6M | |
| Other Inc / (Exp) | $9K | -$15K | -$23K | -$28K | -$123K | |
| Operating Expenses | $46.3M | $70.9M | $77.7M | $56.6M | $47.7M | |
| Operating Income | -$23.5M | -$42.2M | -$45.7M | -$24.6M | -$13.7M | |
| Net Interest Expenses | $3.9M | $4.4M | -- | -- | $1.4M | |
| EBT. Incl. Unusual Items | -$27.3M | -$46.7M | -$45.6M | -$22M | -$15.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $14K | -$6.7M | $156K | $59K | -$475K | |
| Net Income to Company | -$27.3M | -$40M | -$45.7M | -$22M | -$14.7M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$27.3M | -$40M | -$45.7M | -$22M | -$14.7M | |
| Basic EPS (Cont. Ops) | -$0.68 | -$0.82 | -$0.84 | -$0.39 | -$0.24 | |
| Diluted EPS (Cont. Ops) | -$0.68 | -$0.82 | -$0.84 | -$0.39 | -$0.24 | |
| Weighted Average Basic Share | $40.3M | $49M | $54.3M | $56.7M | $60.4M | |
| Weighted Average Diluted Share | $40.3M | $49M | $54.3M | $56.7M | $60.4M | |
| EBITDA | -$18.1M | -$31.6M | -$31.4M | -$10M | $908K | |
| EBIT | -$23.1M | -$42.2M | -$43.8M | -$20.2M | -$9.1M | |
| Revenue (Reported) | $47.2M | $61.7M | $68.4M | $73.8M | $76.4M | |
| Operating Income (Reported) | -$23.5M | -$42.2M | -$45.7M | -$24.6M | -$13.7M | |
| Operating Income (Adjusted) | -$23.1M | -$42.2M | -$43.8M | -$20.2M | -$9.1M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $179.1M | $230.5M | $271.8M | $290M | $302.1M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $93.2M | $117M | $138.8M | $157.6M | $165.5M | |
| Gross Profit | $85.8M | $113.5M | $133M | $132.4M | $136.6M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $51.6M | $60.2M | $73.5M | $72M | $63.2M | |
| Selling, General & Admin | $91.8M | $156.7M | $159.9M | $147.7M | $117M | |
| Other Inc / (Exp) | -$8.5M | -$58K | -$101K | -$42K | -$140K | |
| Operating Expenses | $156.7M | $251.3M | $281M | $263.2M | $221.7M | |
| Operating Income | -$70.9M | -$137.8M | -$148M | -$130.9M | -$85.1M | |
| Net Interest Expenses | $8M | $16.1M | $7M | -- | -- | |
| EBT. Incl. Unusual Items | -$87.4M | -$154M | -$155.1M | -$123.3M | -$79.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$1.1M | -$6.7M | -$4.5M | $272K | -$149K | |
| Net Income to Company | -$86.3M | -$147.2M | -$150.6M | -$123.6M | -$79.1M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$86.3M | -$147.2M | -$150.6M | -$123.6M | -$79.1M | |
| Basic EPS (Cont. Ops) | -$2.25 | -$3.28 | -$2.82 | -$2.23 | -$1.35 | |
| Diluted EPS (Cont. Ops) | -$2.25 | -$3.28 | -$2.94 | -$2.23 | -$1.35 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -$65.8M | -$104.8M | -$98.4M | -$72.5M | -$26.2M | |
| EBIT | -$79.1M | -$139.1M | -$146M | -$116.1M | -$67.7M | |
| Revenue (Reported) | $179.1M | $230.5M | $271.8M | $290M | $302.1M | |
| Operating Income (Reported) | -$70.9M | -$137.8M | -$148M | -$130.9M | -$85.1M | |
| Operating Income (Adjusted) | -$79.1M | -$139.1M | -$146M | -$116.1M | -$67.7M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $135.6M | $177.2M | $207.1M | $220.9M | $227M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $71.5M | $90.5M | $104.9M | $119.5M | $120.9M | |
| Gross Profit | $64M | $86.7M | $102.1M | $101.3M | $106.1M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $38.5M | $45.3M | $56.1M | $52.3M | $42.9M | |
| Selling, General & Admin | $71.7M | $113.8M | $112.7M | $111.2M | $84.3M | |
| Other Inc / (Exp) | -$8.4M | $10K | -$101K | -$17K | -$161K | |
| Operating Expenses | $121.2M | $185.6M | $205.4M | $195.4M | $158.4M | |
| Operating Income | -$57.2M | -$98.9M | -$103.3M | -$94.1M | -$52.3M | |
| Net Interest Expenses | $7.6M | $12.1M | $2.8M | -- | $1.4M | |
| EBT. Incl. Unusual Items | -$73.2M | -$111M | -$106M | -$87.6M | -$49.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$1.2M | -$6.7M | -$4.3M | $213K | -$292K | |
| Net Income to Company | -$72M | -$104.2M | -$101.6M | -$87.8M | -$48.8M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$72M | -$104.2M | -$101.6M | -$87.8M | -$48.8M | |
| Basic EPS (Cont. Ops) | -$1.86 | -$2.27 | -$1.88 | -$1.57 | -$0.82 | |
| Diluted EPS (Cont. Ops) | -$1.86 | -$2.27 | -$2.00 | -$1.57 | -$0.82 | |
| Weighted Average Basic Share | $115.5M | $137.8M | $161M | $168.2M | $178.3M | |
| Weighted Average Diluted Share | $115.5M | $137.8M | $161.2M | $168.2M | $178.3M | |
| EBITDA | -$52.7M | -$71.6M | -$63.9M | -$50.2M | -$8.2M | |
| EBIT | -$63.7M | -$98.2M | -$100.5M | -$82.2M | -$39.3M | |
| Revenue (Reported) | $135.6M | $177.2M | $207.1M | $220.9M | $227M | |
| Operating Income (Reported) | -$57.2M | -$98.9M | -$103.3M | -$94.1M | -$52.3M | |
| Operating Income (Adjusted) | -$63.7M | -$98.2M | -$100.5M | -$82.2M | -$39.3M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $18M | $92M | $193.2M | $116.3M | $106.3M | |
| Short Term Investments | $210.2M | $178.9M | $251.8M | $247.2M | $211.5M | |
| Accounts Receivable, Net | $27.6M | $48.3M | $48.8M | $48M | $60.3M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $8.4M | $10.6M | -- | -- | -- | |
| Other Current Assets | -- | -- | $14.6M | $16.3M | $15.4M | |
| Total Current Assets | $264.2M | $329.8M | $508.4M | $427.8M | $393.4M | |
| Property Plant And Equipment | $8.1M | $37.6M | $44.4M | $42.6M | $39.6M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $3.7M | $107.8M | $170M | $186M | $190.7M | |
| Other Intangibles | $25.5M | $98.9M | $104.8M | $92.2M | $73.4M | |
| Other Long-Term Assets | $810K | $3.6M | $4.5M | $3.7M | $4.7M | |
| Total Assets | $302.4M | $577.7M | $832.1M | $752.3M | $701.8M | |
| Accounts Payable | $3.6M | $5.3M | $4.7M | $4.4M | $6.6M | |
| Accrued Expenses | $4.7M | $6.7M | $6.3M | $7.5M | $11.6M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $2.8M | $2.6M | $3.4M | $3.4M | $3.4M | |
| Other Current Liabilities | -- | $14.4M | $4.6M | -- | -- | |
| Total Current Liabilities | $48.2M | $88M | $93.1M | $82.5M | $89M | |
| Long-Term Debt | $48.2M | $169M | $180.9M | $226.5M | $228M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $101.7M | $301.6M | $310M | $327.3M | $334.9M | |
| Common Stock | $37K | $43K | $1.4B | $1.4B | $1.5B | |
| Other Common Equity Adj | $72K | $61K | -$67K | -$648K | $33K | |
| Common Equity | $200.6M | $276.1M | $522.1M | $425M | $366.9M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $200.6M | $276.1M | $522.1M | $425M | $366.9M | |
| Total Liabilities and Equity | $302.4M | $577.7M | $832.1M | $752.3M | $701.8M | |
| Cash and Short Terms | $228.3M | $270.9M | $445M | $363.5M | $317.7M | |
| Total Debt | $48.2M | $169M | $180.9M | $226.5M | $228M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $111.2M | $275.8M | $124.2M | $95M | $328.3M | |
| Short Term Investments | $163.9M | $179.4M | $255.9M | $252.7M | $58.9M | |
| Accounts Receivable, Net | $36.3M | $47.7M | $49.5M | $46.1M | $51.6M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $11.3M | $12.5M | $13.8M | -- | -- | |
| Other Current Assets | -- | -- | -- | $14.7M | $18.5M | |
| Total Current Assets | $322.8M | $515.3M | $443.5M | $408.5M | $457.4M | |
| Property Plant And Equipment | $31.2M | $42.6M | $42.3M | $41.4M | $39.1M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $107.8M | $169.7M | $186M | $186M | $234.4M | |
| Other Intangibles | $105.9M | $113.6M | $100.7M | $72M | $76.5M | |
| Other Long-Term Assets | $3M | $4.3M | $3.8M | $5.1M | $5.7M | |
| Total Assets | $570.7M | $845.5M | $776.2M | $712.9M | $813.1M | |
| Accounts Payable | $5.2M | $4.8M | $6.8M | $6.3M | $14.3M | |
| Accrued Expenses | $7M | $7M | $9.2M | $10.3M | $13.7M | |
| Current Portion Of Long-Term Debt | -- | $177.8M | -- | -- | $230.4M | |
| Current Portion Of Capital Lease Obligations | $2.4M | $2.3M | $3.5M | $3.4M | $3.3M | |
| Other Current Liabilities | $5.9M | $2.6M | -- | -- | -- | |
| Total Current Liabilities | $65.9M | $263.4M | $91.1M | $84.3M | $323.8M | |
| Long-Term Debt | $166.2M | -- | $226.1M | $227.7M | $114.6M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $271M | $296.3M | $336.2M | $330.5M | $458M | |
| Common Stock | $42K | $52K | $54K | $1.5B | $1.5B | |
| Other Common Equity Adj | $66K | -$10K | -$879K | -$170K | -$110K | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $299.6M | $549.2M | $440M | $382.4M | $355M | |
| Total Liabilities and Equity | $570.7M | $845.5M | $776.2M | $712.9M | $813.1M | |
| Cash and Short Terms | $275.1M | $455.2M | $380.1M | $347.7M | $387.3M | |
| Total Debt | $166.2M | $177.8M | $226.1M | $227.7M | $345M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$60.1M | -$115M | -$153.2M | -$137.4M | -$118.1M | |
| Depreciation & Amoritzation | $9.2M | $18.7M | $37.5M | $48.3M | $42.2M | |
| Stock-Based Compensation | $17.8M | $38M | $65.1M | $72.1M | $55.8M | |
| Change in Accounts Receivable | $127K | -$16.4M | $102K | $788K | -$13.7M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$32.2M | -$26.1M | -$23.1M | -$35.3M | -$33.1M | |
| Capital Expenditures | $4.3M | $10.5M | $18.5M | $17.4M | $14.3M | |
| Cash Acquisitions | -- | -$101.7M | -$46.8M | -$27.8M | -$11.4M | |
| Cash From Investing | -$209.6M | -$82.6M | -$139.7M | -$39M | $20.3M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $47.2M | $222.5M | -- | -- | -- | |
| Long-Term Debt Repaid | -$21.8M | -$57M | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -$8.4M | -$1.8M | |
| Other Financing Activities | -$6.3M | -$23.4M | -$6.3M | -$1.3M | -- | |
| Cash From Financing | $231.4M | $182.6M | $264.1M | -$2.6M | $2.7M | |
| Beginning Cash (CF) | $28.4M | $18M | $92M | $193.2M | $116.3M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$10.4M | $73.9M | $101.3M | -$76.9M | -$10.1M | |
| Ending Cash (CF) | $18M | $92M | $193.2M | $116.3M | $106.3M | |
| Levered Free Cash Flow | -$36.5M | -$36.6M | -$41.6M | -$52.7M | -$47.4M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$27.3M | -$40M | -$45.7M | -$22M | -$14.7M | |
| Depreciation & Amoritzation | $5M | $10.7M | $12.4M | $10.2M | $10M | |
| Stock-Based Compensation | $9.5M | $17.5M | $17.3M | $14.2M | $9.5M | |
| Change in Accounts Receivable | $2.7M | $94K | -$2.1M | $6.2M | $4.3M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$4.5M | -$5.4M | -$12M | $3.1M | $6.2M | |
| Capital Expenditures | $1.1M | $3.9M | $4.2M | $3.1M | $4.4M | |
| Cash Acquisitions | -$87.2M | -$46.8M | -- | -- | -$36.2M | |
| Cash From Investing | -$4M | -$172.8M | -$33.2M | -$24.9M | $7.6M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | $115.5M | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -$646K | |
| Repurchase of Common Stock | -- | -- | -$8.4M | -- | -- | |
| Other Financing Activities | -- | -$930K | -$412K | -- | -$3M | |
| Cash From Financing | $15.5M | $248.8M | -$7.5M | $1M | $112.5M | |
| Beginning Cash (CF) | $104.2M | $205.1M | $177M | $115.7M | $201.9M | |
| Foreign Exchange Rate Adjustment | $14K | -$9K | -$7K | -$15K | $83K | |
| Additions / Reductions | $7M | $70.7M | -$52.8M | -$20.7M | $126.3M | |
| Ending Cash (CF) | $111.2M | $275.8M | $124.2M | $95M | $328.3M | |
| Levered Free Cash Flow | -$5.6M | -$9.3M | -$16.2M | $6K | $1.8M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$86.3M | -$147.2M | -$150.6M | -$123.6M | -$79.1M | |
| Depreciation & Amoritzation | $13.3M | $34.4M | $47.6M | $43.6M | $41.5M | |
| Stock-Based Compensation | $32.1M | $59.4M | $69.8M | $61.5M | $42.3M | |
| Change in Accounts Receivable | -$1M | -$11M | -$1.7M | $1.8M | -$7.6M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$35.1M | -$17.5M | -$30.2M | -$28.9M | -$955K | |
| Capital Expenditures | $4.2M | $21.9M | $16.8M | $15.6M | $14.6M | |
| Cash Acquisitions | -$102.5M | -$45.9M | -$27.8M | -- | -$66.3M | |
| Cash From Investing | -$82.7M | -$84.9M | -$122M | -$3.4M | $119.8M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -$8.4M | -$1.8M | -- | |
| Other Financing Activities | -$24.9M | -$7.2M | -$1.3M | -- | -- | |
| Cash From Financing | $177M | $266.9M | $666K | $3M | $114.5M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $59.2M | $164.5M | -$151.5M | -$29.3M | $233.3M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$39.3M | -$39.4M | -$47M | -$44.5M | -$15.5M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$72M | -$104.2M | -$101.6M | -$87.8M | -$48.8M | |
| Depreciation & Amoritzation | $11M | $26.6M | $36.6M | $31.9M | $31.2M | |
| Stock-Based Compensation | $27.3M | $48.7M | $53.4M | $42.7M | $29.3M | |
| Change in Accounts Receivable | -$4.5M | $1M | -$800K | $259K | $6.3M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$22M | -$13.3M | -$20.4M | -$14M | $18.1M | |
| Capital Expenditures | $3.3M | $14.7M | $13.1M | $11.3M | $11.6M | |
| Cash Acquisitions | -$102.5M | -$46.8M | -$27.8M | -- | -$54.9M | |
| Cash From Investing | -$60.7M | -$63M | -$45.3M | -$9.6M | $89.8M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $222.5M | -- | -- | -- | $115.5M | |
| Long-Term Debt Repaid | -$57M | -- | -- | -- | -$646K | |
| Repurchase of Common Stock | -- | -- | -$8.4M | -$1.8M | -- | |
| Other Financing Activities | -$22.5M | -$6.3M | -$1.3M | -- | -$3M | |
| Cash From Financing | $175.9M | $260.2M | -$3.3M | $2.3M | $114.1M | |
| Beginning Cash (CF) | $183.2M | $429.7M | $568.6M | $365.5M | $509.5M | |
| Foreign Exchange Rate Adjustment | $5K | -$14K | -$27K | -$13K | $62K | |
| Additions / Reductions | $93.2M | $183.8M | -$69M | -$21.3M | $222M | |
| Ending Cash (CF) | $276.4M | $613.5M | $499.6M | $344.1M | $731.6M | |
| Levered Free Cash Flow | -$25.3M | -$28.1M | -$33.5M | -$25.3M | $6.5M | |
Get HCAT Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
HCAT
Sector
P/E ratio
--
25.86x
PEG ratio
--
0.00x
P/B ratio
1.22x
1.85x
Price / LTM sales
1.39x
1.86x
Growth Metrics
HCAT
Sector
Revenue growth
3.5%
7.28%
Earnings growth
--
1.82%
Revenue (5-year growth)
21.33%
8.73%
Earnings forecast
$0.09
-$0.20
Profitability
HCAT
Sector
Profitability FY 2023
$131.8M
$57.1M
Return on invested capital
-12.86%
-14.06%
Return on assets
-10.95%
-11.77%
Return on equity
-21.76%
-14.78%
Earnings Date
Last Earnings Date
Nov
6
Next Earnings Date
Feb
21
Estimated Next Earnings Date
Feb
5
Balance Sheet
HCAT
Sector
Total cash
$387.3M
$47M
Short term investments
$211.5M
$45.2M
Total assets
$701.8M
$142.6M
Long term debt
$345M
$6.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
